Pfizer fails phase 3 C. diff vaccine test but still spies possible path forward
Pfizer fails phase 3 C. diff vaccine test but still [...]
Gemini CEO out the door as 80% of staff laid off, strategic review gets underway
Gemini CEO out the door as 80% of staff laid [...]
FDA sticks a fork in Reata’s treatment for chronic kidney disease
FDA sticks a fork in Reata’s treatment for chronic kidney [...]
Amryt’s shares tumble as FDA stiff-arms skin treatment, a month after EU delay revealed
Amryt’s shares tumble as FDA stiff-arms skin treatment, a month [...]
Russian invasion of Ukraine could affect more than 200 clinical trials across biotech and pharma
Russian invasion of Ukraine could affect more than 200 clinical [...]
AbbVie ditches fibrosis program it paid Morphic $20M for in 2020
AbbVie ditches fibrosis program it paid Morphic $20M for in [...]
Takeda, Arch back hC Bioscience with $24M for transfer RNAs, following Flagship into the field
Takeda, Arch back hC Bioscience with $24M for transfer RNAs, [...]
Orphazyme goes soul searching as EU advisers add 2nd rejection for rare disease drug
Orphazyme goes soul searching as EU advisers add 2nd rejection [...]
Merck cuts ties to Moderna’s early-phase KRAS vaccine, leaving mRNA specialist to mull next steps
Merck cuts ties to Moderna’s early-phase KRAS vaccine, leaving mRNA [...]
Amicus’ gene therapy SPAC merger folds, turning pipeline and R&D into target of $400M in cuts
Amicus’ gene therapy SPAC merger folds, turning pipeline and R&D [...]